How long will I receive my bispecific antibody therapy?

As of July 2024, bispecific antibody therapy has been designed to be given until disease progression or until the side effects of said therapy become too overwhelming. 

Keep an open communication with your healthcare team about how you are feeling about the treatment. While some patients have hardly any side effects, everyone is different, and you might have a harder time with the drug’s side effect profile than someone else.